Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» In a setback, Bayer, J&J say their big PhIII secondary stroke trial for Xarelto failed
In a setback, Bayer, J&J say their big PhIII secondary stroke trial for Xarelto failed
In a setback, Bayer, J&J say their big PhIII secondary stroke trial for Xarelto failed
Submitted by
admin
on October 6, 2017 - 9:47am
Source:
Endpoints
News Tags:
Bayer
JNJ
stroke
clinical trials
Xarelto
bloodthinners
Headline:
In a setback, Bayer, J&J say their big PhIII secondary stroke trial for Xarelto failed
Do Not Allow Advertisers to Use My Personal information
